Deep Genomics
Agent35Agent Readiness: 35/100. Below median. Measured by StartupHub.ai. Median 41.Trust80Data Trust: 80/100. Top 25%. Measured by StartupHub.ai. Median 61.AI-powered biotechnology company developing RNA therapeutics for genetic diseases.
About
Deep Genomics is an AI-driven genetic medicines platform company that uses its Biological Foundation (BioFM) Model Platform to solve complex molecular design and target biology problems. This platform enables the discovery and development of novel genetic medicines by integrating AI model development, screening technologies, and lab-in-the-loop workflows. They aim to transform drug discovery by finding molecules and targets others would miss, accelerating the development of life-changing medicines for patients.
Listed competitors
Also in this space
Clinical-stage precision medicine company using protein motion insights for drug discovery.
Shares Biotech, Drug Discovery
AI-powered insights platform for life sciences and biotech workflows.
Shares Biotech, Drug Discovery
AI-driven diagnostics that convert medical images into actionable genomic insights for faster cancer treatment decisions.
Shares Genomics
Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.
Shares Biotech, Genomics
Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.
Shares Biotech, Genomics
A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.
Shares Biotech, Genomics
Key facts
- Website
- deepgenomics.com
- Headquarters
- Toronto, Canada
- Founded
- 2015
- Employees
- 110
- Total funding
- $241M (Series C)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 28 Jul 2021 | Series C | $180M | SoftBank Vision Fund 2 |
| 7 Jan 2020 | Series B | $40M | Future Ventures |
| 25 Sept 2017 | Series A | $13M | Khosla Ventures |
| 18 Nov 2015 | Seed | $8M |
Tech stack
Detected on deepgenomics.com, last scanned 31 Oct 2026. Run your own scan
- CMS / Builders
- Webflow
- CDN
- Cloudflare
- Email provider
- Google Workspace
Test your Ahrefs DR
The backlink strength of a domain, on the Ahrefs 0 to 100 scale. About a minute.
Frequently asked
Is Deep Genomics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Deep Genomics is 80 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has Deep Genomics raised?
Deep Genomics has raised a total of $241M in funding. The most recent round on record is Series C.
How many employees does Deep Genomics have?
Deep Genomics has approximately 110 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for Deep Genomics:
Company details: from public sources. Funding: no announced round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
